LabCorp launches novel coronavirus test

LabPulse.com staff writers
Mar 9, 2020
2019 08 02 23 46 0673 Lab Vacutainer Test Tube 400

LabCorp has released a nucleic acid amplification (NAA) test for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.

LabCorp developed the test internally, and it is making it available according to guidance posted by the U.S. Food and Drug Administration (FDA) on February 29. The qualitative assay uses polymerase chain reaction (PCR) technology and has been validated for use with respiratory samples, the company said. Results are available in three to four days.

The company is also able to perform the U.S. Centers for Disease Control and Prevention's 2019-nCoV real-time reverse transcription PCR diagnostic panel, it said.

Latest in 510(k)
Fda Button Social
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
June 6, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Fda Button Social
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
March 20, 2023
Bd Vaginal Panel Cor System
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
March 16, 2023
Related Stories
2020 04 22 18 18 5522 Coronavirus Cells Lungs 400
COVID-19
LabCorp broadens SARS-CoV-2 serology test availability
2019 05 28 23 15 8753 Doctor Patient Consult Tablet 400
COVID-19
LabCorp, Ciox Health to create COVID-19 patient database
2019 04 25 18 38 1277 Stop Access Sign 400
Health Topics
ASM: Reagent shortages threaten coronavirus test access
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in 510(k)
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
By LabPulse.com staff writers
The device has conducted more than 180 thousand assessments in pharmacies and primary care clinics in Europe; DeepX is poised to enter the U.S. market.
June 6, 2023
Fda Button Social
Leica Biosystems granted FDA clearance for Class II mismatch repair panel
By LabPulse.com staff writers
The Bond MMR Antibody Panel is available for clinical use on its automated Bond-III and Bond-Max immunohistochemistry instruments.
April 3, 2023
Digital Pathology Cytology Social
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
By Leo O'Connor
The test detects and differentiates influenza A, influenza B, and SARS-CoV-2 viruses to help ensure physicians can recommend the most appropriate treatment for each patient.
March 20, 2023
Fda Button Social
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
By LabPulse.com staff writers
The BD vaginal panel running on the high-throughput BD Cor molecular diagnostic system tests for multiple common types of vaginitis using only a swab and one test.
March 16, 2023
Bd Vaginal Panel Cor System
FDA grants clearance to Abbott for first commercial laboratory test to detect traumatic brain injury
By LabPulse.com staff writers
The test runs on Abbott's Alinity i laboratory immunoassay instrument, providing a result in 18 minutes to help clinicians quickly assess concussion and triage patients, Abbott said. Negative results rule out the need for a CT scan.
March 7, 2023
Football Player Concussion Social
Copan Diagnostics receives second FDA clearance for semiautomated preanalytical processor
By LabPulse.com staff writers
With this second clearance, Colibri can prepare microbial suspensions for antibiotic susceptibility testing with the BioMérieux Vitek 2 system.
October 11, 2022
Lab Virus Bacteria Research
OIG: FDA recommendations for future pandemics
By Leo O'Connor
OIG offered numerous recommendations to manage such infectious disease emergencies, saying the FDA should access and, when appropriate, revise its guidance for Emergency Use Authorization (EUA) submissions for tests.
September 21, 2022
2021 11 29 23 50 3003 Fda Button 20211129235739
Week in Review: Multicancer early detection at ESMO, DiaSorin nabs FDA clearance for COVID-19 kit, IVD industry urges Congress to enact SALSA, and more
By Leo O'Connor
Dear LabPulse.com member,
September 14, 2022
FDA grants 510(k) clearance to DiaSorin for COVID-19 kit
By LabPulse.com staff writers
The kit, which runs on DiaSorin's Liaison MDX molecular diagnostics system, provides a sample-to-answer test for the detection of SARS-CoV-2 directly from nasopharyngeal or nasal swab specimens.
September 13, 2022
2021 08 23 18 25 2180 Covid Treatment Doctor 400
PixCell Medical, Insight Medical to distribute hematology analyzer
By LabPulse.com staff writers
PixCell said that its HemoScreen hematology analyzer delivers lab-grade diagnostics at the point of care without the need for external reagents or extensive training.
September 5, 2022
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Cue Health requests FDA de novo clearance for at-home flu test
By LabPulse.com staff writers
Clearance would permit the test to be used at home and elsewhere at the point-of-care (POC).
September 1, 2022
2022 09 02 19 52 9683 Flu Season Ahead 400
NanoDx, SkyWater launch nano biosensor
By LabPulse.com staff writers
The companies said that as a result of the development, NanoDx is ready to prepare and submit the product for review by the U.S. Food and Drug Administration (FDA) with the aim of eventually commercializing a product based on the technology.
August 25, 2022
2021 06 30 22 19 4138 Digital Science Lab 400
Page 1 of 16
Next Page